FDA approves Sanofi Pasteurs 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) to include children age 6 through 35 months.
FDA puts a partial clinical hold on Advaxis Phase 3 trial of AXAL for cervical cancer.
FDA approves a Teligent ANDA for a generic copy of Fougera Pharmaceuticals Temovate (clobetasol propionate ointment USP) 0.05%.
AdvaMed proposes legislation to allow FDA to continue to collect user fees and review medical device applications associated with those fees during an...
The Supreme Court refuses to reinstate Hellsins Aloxi patent, supporting Tevas launch of a generic form of the anti-nausea drug last year.
Attorneys general in 46 states reach a $120 million settlement with DePuy to resolve complaints that the company illegally promoted two metal-on-metal...
FDA clears a Perspectum Diagnostics 510(k) for MRCP+ biliary visualization software.
Torrent Pharmaceuticals expands its recall from 10 lots of losartan potassium tablets to include six lots of losartan potassium and hydrochlorothiazid...